Yeast as carrier for drug delivery and vaccine construction
Y Tan, L Chen, K Li, B Lou, Y Liu, Z Liu - Journal of Controlled Release, 2022 - Elsevier
Yeast has been employed as an effective derived drug carrier as a unicellular
microorganism. Many research works have been devoted to the encapsulation of nucleic …
microorganism. Many research works have been devoted to the encapsulation of nucleic …
Molecular dynamics: new frontier in personalized medicine
The field of drug discovery has witnessed infinite development over the last decade with the
demand for discovery of novel efficient lead compounds. Although the development of novel …
demand for discovery of novel efficient lead compounds. Although the development of novel …
Phenotype determines nanoparticle uptake by human macrophages from liver and blood
A significant challenge to delivering therapeutic doses of nanoparticles to targeted disease
sites is the fact that most nanoparticles become trapped in the liver. Liver-resident …
sites is the fact that most nanoparticles become trapped in the liver. Liver-resident …
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
Z Jing, S Wang, K Xu, Q Tang, W Li, W Zheng… - Advanced …, 2022 - Wiley Online Library
Therapeutic tumor neoantigen vaccines have been widely studied given their good safety
profile and ability to avoid central thymic tolerance. However, targeting antigen‐presenting …
profile and ability to avoid central thymic tolerance. However, targeting antigen‐presenting …
Magnetic field-assisted aligned patterning in an alginate-silk fibroin/nanocellulose composite for guided wound healing
This study was focused on utilizing the magneto-responsiveness of cellulose nanocrystals
(CNCs) in an alginate-silk fibroin (ASF) matrix under a low-strength (0.28 T) magnetic field …
(CNCs) in an alginate-silk fibroin (ASF) matrix under a low-strength (0.28 T) magnetic field …
Entrapping of nanoparticles in yeast cell wall microparticles for macrophage-targeted oral delivery of cabazitaxel
T Ren, J Gou, W Sun, X Tao, X Tan… - Molecular …, 2018 - ACS Publications
In this work, a nano-in-micro carrier was constructed by loading polymer–lipid hybrid
nanoparticles (NPs) into porous and hollow yeast cell wall microparticles (YPs) for …
nanoparticles (NPs) into porous and hollow yeast cell wall microparticles (YPs) for …
[HTML][HTML] Preparation and characterization of beta-glucan particles containing a payload of nanoembedded rifabutin for enhanced targeted delivery to macrophages
TK Upadhyay, N Fatima, D Sharma… - EXCLI …, 2017 - ncbi.nlm.nih.gov
Abstract β-glucan particles (GP) are polymeric carbohydrates, mainly found as components
of cell wall fungi, yeast, bacteria and also in cereals such as barley and oat, and have been …
of cell wall fungi, yeast, bacteria and also in cereals such as barley and oat, and have been …
Polysaccharide dual coating of yeast capsules for stabilization of anthocyanins
C Tan, J Wang, B Sun - Food Chemistry, 2021 - Elsevier
The dual coated yeast capsules for anthocyanin encapsulation and stabilization were
fabricated. Anthocyanins were preloaded in hollow yeast capsules, and then the dual …
fabricated. Anthocyanins were preloaded in hollow yeast capsules, and then the dual …
Curcumin encapsulation in yeast glucan particles promotes its anti-inflammatory potential in vitro
Abstract Glucan particles (GPs) from Saccharomyces cerevisiae are hollow shells that are
composed mainly of β-1, 3-d-glucan, which has demonstrated immunomodulatory and anti …
composed mainly of β-1, 3-d-glucan, which has demonstrated immunomodulatory and anti …
Nanotechnology in glycomics: applications in diagnostics, therapy, imaging, and separation processes
E Dosekova, J Filip, T Bertok, P Both… - Medicinal research …, 2017 - Wiley Online Library
This review comprehensively covers the most recent achievements (from 2013) in the
successful integration of nanomaterials in the field of glycomics. The first part of the paper …
successful integration of nanomaterials in the field of glycomics. The first part of the paper …